Drawing for ECHIPURE

USPTO serial 75590046

ECHIPURE

Reviewed by CopyMark Law Group

Reg. 2720225Status 710
Filing date
Status date
Registration date
Jun 3, 2003
Examiner
JOHNSON, AISHA CLARKE
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ECHIPURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

TIMOTHY X GIBSON

TIMOTHY X GIBSON KAPLAN & GILMAN, LLP900 RT 9 NWOODBRIDGE, NJ 07095UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Plant extracts for use in the manufacture of pharmaceutical preparations and bulk pharmaceutical preparations, and raw materials for pharmaceutical preparationsSECTION 8 - CANCELLED—
005Pharmaceutical preparations, namely, plant extracts for use in the treatment of angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting and allergy; pharmaceutical preparations, namely, plant extracts with antidepressant, diuretic, hypnotic, sedative, stimulant and tranquilizer qualities for use in the treatment of insomnia; pharmaceutical preparations, namely, hemorrhoidal ointment, laxatives, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; pharmaceutical preparations, namely, medicaments for the treatment of gynecological disorders, menstruation circulation regulating tablets, drugs for circulatory organs, hormone preparations, anti-inflammatory agents for urinary, genital and anal organs, immunodiagnostic agents for blood clots, analgesic antiphologistic for use in gynecological oriental medicine, pills for treating dizziness, medicaments for regulation of immune system disorders; pharmaceutical preparations for the treatment of womens' diseases, namely, autonomics, antispasmodics, diaphoretics and anhidrotics; pharmaceutical preparations for treating migraine and depression; pharmaceutical preparations, namely, medicines for the treatment of breast pain; pharmaceutical preparations, namely, gynecology drugs for use in regulating and treating menstruation, sterility, menstrual syndromes, mamma, mastopathy, and mastodynia; food supplements containing plant extracts, food supplements derived from plants or plant extracts; dietetic substances derived from plants, adapted for medical use, namely, food for medically restricted diets, food for diabetics, dietary food supplements, and vitamin and mineral supplements, herb teas for medicinal purposes, medicinal teasSECTION 8 - CANCELLED—
030Herb teasSECTION 8 - CANCELLED—
031Live plants; dried plantsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 9, 2010C8..CANCELLED SEC. 8 (6-YR)—
Jun 9, 2008CFITCASE FILE IN TICRS—
Jun 3, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 23, 2002DOCKASSIGNED TO EXAMINER—
Dec 16, 2002PCGRPETITION TO DIRECTOR GRANTED—
Nov 1, 2002MAILPAPER RECEIVED—
Aug 19, 2002MAILPAPER RECEIVED—
Aug 14, 20021.BDSec. 1(B) CLAIM DELETED—
Aug 14, 2002IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 14, 200244EASEC. 44(E) CLAIM ADDED—
Aug 14, 2002PCRCPETITION TO DIRECTOR RECEIVED—
Aug 14, 2002MAILPAPER RECEIVED—
Jun 21, 2002EX2GSOU EXTENSION 2 GRANTED—
May 21, 2002EXT2SOU EXTENSION 2 FILED—
Nov 21, 2001EX1GSOU EXTENSION 1 GRANTED—
Nov 9, 2001EXT1SOU EXTENSION 1 FILED—
Jun 19, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 27, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 14, 2001NPUBNOTICE OF PUBLICATION—
Sep 22, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 26, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 10, 2000CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 25, 2000DOCKASSIGNED TO EXAMINER—
Dec 6, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 14, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance